Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG)

British Journal of Haematology, 05/14/2012

The findings suggest that the combination of bendamustine and mitoxantrone is an active regime in relapsed or refractory chronic lymphocytic leukaemia (CLL).

Print Article Summary Cat 2 CME Report